Dr Reddys Laboratories Share Price Today - Live Blog for July 22, 2025

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.00% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,240.65 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,241.15 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,240.50. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's share price has dropped by -0.09%, a development that warrants careful analysis. Presently trading at ₹1,239.00, investors are assessing whether this presents an opportunity or a risk.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% drop, and it's now trading at ₹1,240.15 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.25% drop, and it's now trading at ₹1,240.15 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,242.65. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5900, while the industry PE is 35.9113.

The share price of Dr Reddys Laboratories Ltd experienced a -0.34% slump and is currently trading at ₹1,243.00. While the stock maintains a PE ratio of 18.5900, the industry PE is 35.9113, raising questions about valuation.

Dr Reddys Laboratories Ltd witnessed a -0.02% decrease in its share price, and it is currently trading at ₹1,246.85. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.5900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

After a notable 0.35% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,247.90. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's stock has surged by 0.07%, and it is currently trading at ₹1,243.50. Additionally, the stock maintains a PE ratio of 18.5900, while the industry PE is 35.9113.

The share price of Dr Reddys Laboratories Ltd plunged by -0.43%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,239.10, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd is facing a -0.43% decline and is currently trading at ₹1,239.10 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.43% slump and is currently trading at ₹1,239.10. While the stock maintains a PE ratio of 18.5900, the industry PE is 35.9113, raising questions about valuation.

Dr Reddys Laboratories Ltd witnessed a substantial 0.38% increase in its share price and is currently trading at ₹1,243.15. This remarkable performance has caught the eye of investors.

There was no change in the share price of Dr Reddys Laboratories Ltd, and it continues to trade at ₹1,238.45. The stock has a PE ratio of 18.5900, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

There was no alteration in the share price of Dr Reddys Laboratories Ltd, and it is currently trading at ₹1,238.45. This lack of change could lead investors to revisit their investment strategies and consider the stock's valuation.

Dr Reddys Laboratories Ltd's share price has dropped by -0.27%, a development that warrants careful analysis. Presently trading at ₹1,241.60, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -0.18% dip in its share price and is currently trading at ₹1,244.70. The stock has a PE ratio of 18.5900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced a -0.05% slump and is currently trading at ₹1,246.45. While the stock maintains a PE ratio of 18.5900, the industry PE is 35.9113, raising questions about valuation.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,246.45. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5900, while the industry PE is 35.9113.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.07% boost, with the current market value at ₹1,247.55 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.03%, a situation worth noting. At present, the stock is trading at ₹1,246.65. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.5900, while the industry PE ratio is 35.9113.

The stock of Dr Reddys Laboratories Ltd suffered a -0.15% drop, and it's now trading at ₹1,247.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd shares experienced a -0.15% reduction, with the current market price at ₹1,247.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd experienced a -0.07% downturn in its share price, and it's currently trading at ₹1,248.95. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.25% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,250.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5900, while the industry PE is 35.9113.

Dr Reddys Laboratories Ltd's share price has fallen by -0.42%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,253.70, and market participants are assessing the implications. The stock has a PE ratio of 18.5900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.